Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2R64

Crystal structure of a 3-aminoindazole compound with CDK2

2R64 の概要
エントリーDOI10.2210/pdb2r64/pdb
関連するPDBエントリー2DUV
分子名称Cell division protein kinase 2, N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE (3 entities in total)
機能のキーワードprotein kinase, inhibitor, cell division, atp-binding, cell cycle, mitosis, nucleotide-binding, phosphorylation, polymorphism, serine/threonine-protein kinase, transferase
由来する生物種Homo sapiens
タンパク質・核酸の鎖数1
化学式量合計34430.04
構造登録者
Lee, J.,Choi, H.,Kim, K.H.,Jeong, S.,Park, J.W.,Baek, C.S.,Lee, S.H. (登録日: 2007-09-05, 公開日: 2008-09-09, 最終更新日: 2024-03-13)
主引用文献Lee, J.,Choi, H.,Kim, K.H.,Jeong, S.,Park, J.W.,Baek, C.S.,Lee, S.H.
Synthesis and biological evaluation of 3,5-diaminoindazoles as cyclin-dependent kinase inhibitors.
Bioorg.Med.Chem.Lett., 18:2292-2295, 2008
Cited by
PubMed Abstract: A novel series of 3,5-diaminoindazoles were prepared and found to be CDK inhibitors. Potent inhibitors against CDK1 and CDK2 were obtained by introduction of 1lambda(6)-isothiazolidine-1,1-dioxide at 5-position of indazole. Anti-proliferative activities of compounds were evaluated using EJ, HCT116, SW620, and A549 cancer cell lines.
PubMed: 18353638
DOI: 10.1016/j.bmcl.2008.03.002
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.3 Å)
構造検証レポート
Validation report summary of 2r64
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon